Drugs / Acellular Adipose Tissue
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02817984 | Apr 2016 → Apr 2017 | — | Johns Hopkins University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Acellular Adipose Tissue | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02817984 ↗ |
| Known as | AAT | “Acellular Adipose Tissue (AAT)” NCT02817984 ↗ |
| Modality | Protein / enzyme biologic | “The components of the adipose-derived scaffold are all naturally occurring AAT proteins and proteoglycans that provide a natural scaffold.” NCT02817984 ↗ |